These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 30617806)
1. Experimental Manipulation of Calpain Activity In Vitro. Kitagawa S Methods Mol Biol; 2019; 1915():209-218. PubMed ID: 30617806 [TBL] [Abstract][Full Text] [Related]
2. Calpain inhibitors stimulate phagocyte functions via activation of human formyl peptide receptors. Fujita H; Kato T; Watanabe N; Takahashi T; Kitagawa S Arch Biochem Biophys; 2011 Sep; 513(1):51-60. PubMed ID: 21723247 [TBL] [Abstract][Full Text] [Related]
3. Stimulation of human formyl peptide receptors by calpain inhibitors: homology modeling of receptors and ligand docking simulation. Fujita H; Kato T; Watanabe N; Takahashi T; Kitagawa S Arch Biochem Biophys; 2011 Dec; 516(2):121-7. PubMed ID: 22005393 [TBL] [Abstract][Full Text] [Related]
4. Apoptosis induced by novel aldehyde calpain inhibitors in human tumor cell lines. Guan N; Korukonda R; Hurh E; Schmittgen TD; Donkor IO; Dalton JT Int J Oncol; 2006 Sep; 29(3):655-63. PubMed ID: 16865282 [TBL] [Abstract][Full Text] [Related]
5. New tripeptide-based macrocyclic calpain inhibitors formed by N-alkylation of histidine. Chen H; Jiao W; Jones MA; Coxon JM; Morton JD; Bickerstaffe R; Pehere AD; Zvarec O; Abell AD Chem Biodivers; 2012 Nov; 9(11):2473-84. PubMed ID: 23161629 [TBL] [Abstract][Full Text] [Related]
6. Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: enhancing cell permeability by conjugation with penetratin. Gil-Parrado S; Assfalg-Machleidt I; Fiorino F; Deluca D; Pfeiler D; Schaschke N; Moroder L; Machleidt W Biol Chem; 2003 Mar; 384(3):395-402. PubMed ID: 12715890 [TBL] [Abstract][Full Text] [Related]
7. Calpain-1 inhibitors for selective treatment of rheumatoid arthritis: what is the future? Miller DJ; Adams SE; Hallett MB; Allemann RK Future Med Chem; 2013 Nov; 5(17):2057-74. PubMed ID: 24215346 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of a reported calpain inhibitor isolated from Streptomyces griseus. Donkor IO; Sanders ML Bioorg Med Chem Lett; 2001 Oct; 11(19):2647-9. PubMed ID: 11551769 [TBL] [Abstract][Full Text] [Related]
9. Developments in the design and synthesis of calpain inhibitors. Neffe AT; Abell AD Curr Opin Drug Discov Devel; 2005 Nov; 8(6):684-700. PubMed ID: 16312145 [TBL] [Abstract][Full Text] [Related]
10. A novel series of urea-based peptidomimetic calpain inhibitors. Sanders ML; Donkor IO Bioorg Med Chem Lett; 2006 Apr; 16(7):1965-8. PubMed ID: 16412635 [TBL] [Abstract][Full Text] [Related]
12. Exploration of the importance of the P2-P3-NHCO-moiety in a potent di- or tripeptide inhibitor of calpain I: insights into the development of nonpeptidic inhibitors of calpain I. Chatterjee S; Iqbal M; Mallya S; Senadhi SE; O'Kane TM; McKenna BA; Bozyczko-Coyne D; Kauer JC; Siman R; Mallamo JP Bioorg Med Chem; 1998 May; 6(5):509-22. PubMed ID: 9629465 [TBL] [Abstract][Full Text] [Related]
13. Calpain inhibitor-induced apoptosis in human prostate adenocarcinoma cells. Zhu W; Murtha PE; Young CY Biochem Biophys Res Commun; 1995 Sep; 214(3):1130-7. PubMed ID: 7575520 [TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of 4-aryl-4-oxobutanoic acid amides as calpain inhibitors. Zhang Y; Jung SY; Jin C; Kim ND; Gong P; Lee YS Bioorg Med Chem Lett; 2009 Jan; 19(2):502-7. PubMed ID: 19041242 [TBL] [Abstract][Full Text] [Related]
15. Structure and physiological function of calpains. Sorimachi H; Ishiura S; Suzuki K Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):721-32. PubMed ID: 9396712 [TBL] [Abstract][Full Text] [Related]